Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe

J Muntwyler; A Cohen-Solai; Nick Freemantle

doi:10.1016/j.ejheart.2004.03.011

Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe

J Muntwyler, A Cohen-Solai, Nick Freemantle

Research output: Contribution to journal › Article

44 Citations (Scopus)

Abstract

AIM: To study the role of sex, age and concomitant diseases for prescription of cardiovascular drugs among patients with heart failure cared for in the community. METHODS AND RESULTS: In 15 European countries, a survey was conducted during 1999 and 2000 among 1363 primary care physicians who included 8256 patients with symptoms of heart failure. Predictors of drug prescription were assessed with multivariate logistic regression. Overall prescription rates for ACE-inhibitors/angiotensin receptor blockers (ACE-I/ARB), beta-blockers, digitalis, diuretics and oral anticoagulants were 69%, 30%, 41%, 75% and 18%. Women had no reduced likelihood to receive ACE-I/ARB and beta-blockers (odds ratio [OR]=0.96 [95% CI 0.87-1.06] and 1.02 [0.92-1.13], respectively), but prescription of oral anticoagulants was decreased (OR=0.74, 95% CI 0.65-0.84). Compared to patients

Original language	English
Pages (from-to)	663-8
Number of pages	6
Journal	European Journal of Heart Failure
Volume	6
DOIs	https://doi.org/10.1016/j.ejheart.2004.03.011
Publication status	Published - 1 Jan 2004

Keywords

ACE-inhibitors
drug utilization
oral anticoagulants
heart failure
beta-blockers
quality of care

Access to Document

10.1016/j.ejheart.2004.03.011

Cite this

@article{b91dd2cf10cf4617b71294b4ce775ff1,

title = "Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe",

abstract = "AIM: To study the role of sex, age and concomitant diseases for prescription of cardiovascular drugs among patients with heart failure cared for in the community. METHODS AND RESULTS: In 15 European countries, a survey was conducted during 1999 and 2000 among 1363 primary care physicians who included 8256 patients with symptoms of heart failure. Predictors of drug prescription were assessed with multivariate logistic regression. Overall prescription rates for ACE-inhibitors/angiotensin receptor blockers (ACE-I/ARB), beta-blockers, digitalis, diuretics and oral anticoagulants were 69%, 30%, 41%, 75% and 18%. Women had no reduced likelihood to receive ACE-I/ARB and beta-blockers (odds ratio [OR]=0.96 [95% CI 0.87-1.06] and 1.02 [0.92-1.13], respectively), but prescription of oral anticoagulants was decreased (OR=0.74, 95% CI 0.65-0.84). Compared to patients ",

keywords = "ACE-inhibitors, drug utilization, oral anticoagulants, heart failure, beta-blockers, quality of care",

author = "J Muntwyler and A Cohen-Solai and Nick Freemantle",

year = "2004",

month = jan,

day = "1",

doi = "10.1016/j.ejheart.2004.03.011",

language = "English",

volume = "6",

pages = "663--8",

journal = "European Journal of Heart Failure",

issn = "1388-9842",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe

AU - Muntwyler, J

AU - Cohen-Solai, A

AU - Freemantle, Nick

PY - 2004/1/1

Y1 - 2004/1/1

N2 - AIM: To study the role of sex, age and concomitant diseases for prescription of cardiovascular drugs among patients with heart failure cared for in the community. METHODS AND RESULTS: In 15 European countries, a survey was conducted during 1999 and 2000 among 1363 primary care physicians who included 8256 patients with symptoms of heart failure. Predictors of drug prescription were assessed with multivariate logistic regression. Overall prescription rates for ACE-inhibitors/angiotensin receptor blockers (ACE-I/ARB), beta-blockers, digitalis, diuretics and oral anticoagulants were 69%, 30%, 41%, 75% and 18%. Women had no reduced likelihood to receive ACE-I/ARB and beta-blockers (odds ratio [OR]=0.96 [95% CI 0.87-1.06] and 1.02 [0.92-1.13], respectively), but prescription of oral anticoagulants was decreased (OR=0.74, 95% CI 0.65-0.84). Compared to patients

AB - AIM: To study the role of sex, age and concomitant diseases for prescription of cardiovascular drugs among patients with heart failure cared for in the community. METHODS AND RESULTS: In 15 European countries, a survey was conducted during 1999 and 2000 among 1363 primary care physicians who included 8256 patients with symptoms of heart failure. Predictors of drug prescription were assessed with multivariate logistic regression. Overall prescription rates for ACE-inhibitors/angiotensin receptor blockers (ACE-I/ARB), beta-blockers, digitalis, diuretics and oral anticoagulants were 69%, 30%, 41%, 75% and 18%. Women had no reduced likelihood to receive ACE-I/ARB and beta-blockers (odds ratio [OR]=0.96 [95% CI 0.87-1.06] and 1.02 [0.92-1.13], respectively), but prescription of oral anticoagulants was decreased (OR=0.74, 95% CI 0.65-0.84). Compared to patients

KW - ACE-inhibitors

KW - drug utilization

KW - oral anticoagulants

KW - heart failure

KW - beta-blockers

KW - quality of care

U2 - 10.1016/j.ejheart.2004.03.011

DO - 10.1016/j.ejheart.2004.03.011

M3 - Article

C2 - 15302016

SN - 1388-9842

VL - 6

SP - 663

EP - 668

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

ER -

Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe

Abstract

Keywords

Access to Document

Fingerprint

Cite this